Nonhematopoietic Erythropoietin Derivatives Prevent Motoneuron Degeneration In Vitro and In Vivo
Tiziana Mennini(Mario Negri Institute for Pharmacological Research), Pietro Ghezzi(Brighton and Sussex Medical School), Marcel Leist(University of Konstanz), Michael Brines(Northwell Health), Barbara Viviani(University of Milano-Bicocca), Lars Torup(University of Messina), Elena Fumagalli(Fondazione IRCCS Istituto Nazionale dei Tumori), Antony Cerami(William K. Warren Foundation), Manuela Mengozzi(Mario Negri Institute for Pharmacological Research), Cristina Mastrotto(Mario Negri Institute for Pharmacological Research), Sara Barbera(Mario Negri Institute for Pharmacological Research), Paolo Bigini(Mario Negri Institute for Pharmacological Research), Johan van Beek(Biogen (Switzerland)), Massimiliano De Paola(Mario Negri Institute for Pharmacological Research), Emanuela Corsini(University of Milan), Marina Marinovich(University of Milan)
Cited by 84
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Clinical Relevance of Biomarkers of Oxidative Stress
|Antioxidants and Redox Signaling|2015|906
Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases
|Journal of Neuroscience|2003|843